Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02013583 · ClinicalTrials.gov registry record
The Glucose Transporter Type I Deficiency (G1D) Registry
A clinical trial, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- 471
- Enrollment target
NCT02013583 is a clinical trial that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 471 participants.
The verdict
NCT02013583 has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- 471 participants
- Enrollment target
Study Summary
The purpose of this protocol is to create a registry for patients diagnosed with Glucose Transporter Type 1 Deficiency (G1D), or patients experiencing symptoms consistent with G1D but not yet diagnosed, to enter medical information for physicians and other health researchers to analyze to increase the understanding of G1D and any sub-diagnoses.
Interventions
- OTHER No intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 471 participants |
| Start Date | 2013-12 |
| Est. Completion | 2024-08-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02013583
The ClinicalTrials.gov registry entry for NCT02013583 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 471 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.
NCT02013583 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02013583 about?
NCT02013583 is a clinical study titled "The Glucose Transporter Type I Deficiency (G1D) Registry". The purpose of this protocol is to create a registry for patients diagnosed with Glucose Transporter Type 1 Deficiency (G1D), or patients experiencing symptoms consistent with G1D but not yet diagnosed, to enter medical information for physicians and other health researchers to analyze to increase t...
What is the current status of trial NCT02013583?
This trial is currently completed. The enrollment target is 471 participants. The study started on 2013-12. Estimated completion is 2024-08-01.
What interventions are being tested in trial NCT02013583?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT02013583?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.